Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Dermatology

Vitiligo

Vitiligo

Vitiligo is an autoimmune condition which results in the loss of melanocytes and consequent depigmentation of the skin. It is thought to affect around 1% of the population and symptoms typically develop by the age of 20-30 years.

Associated conditions
  • type 1 diabetes mellitus
  • Addison's disease
  • autoimmune thyroid disorders
  • pernicious anaemia
  • alopecia areata

Features
  • well-demarcated patches of depigmented skin
  • the peripheries tend to be most affected
  • trauma may precipitate new lesions (Koebner phenomenon)

Vitiligo
Vitiligo
Vitiligo
Vitiligo

Management
  • sunblock for affected areas of skin
  • camouflage make-up
  • topical corticosteroids may reverse the changes if applied early
  • there may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light-skinned patients
+PassMedicine Notes

Vitiligo is an autoimmune condition which results in the loss of melanocytes and consequent depigmentation of the skin. It is thought to affect around 1% of the population and symptoms typically develop by the age of 20-30 years.

Associated conditions
  • type 1 diabetes mellitus
  • Addison's disease
  • autoimmune thyroid disorders
  • pernicious anaemia
  • alopecia areata
Features
  • well-demarcated patches of depigmented skin
  • the peripheries tend to be most affected
  • trauma may precipitate new lesions (Koebner phenomenon)
Management
  • sunblock for affected areas of skin
  • camouflage make-up
  • topical corticosteroids may reverse the changes if applied early
  • there may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light-skinned patients


Links
DermNet NZ
👍 12👎 8
Vitiligo
Saved ✓

MEDIA